Potential cost-effectiveness of C-reactive protein screening followed bytargeted statin therapy for the primary prevention of cardiovasculardisease among patients without overt hyperlipidemia |
Blake, G.J.;Ridker, P.M.;Kuntz, K.M.; |
The American Journal of Medicine |
2003-04-15 |
查看 |